In last trading session, Edgewise Therapeutics Inc (NASDAQ:EWTX) saw 1.58 million shares changing hands with its beta currently measuring 0.20. Company’s recent per share price level of $27.10 trading at $0.43 or 1.61% at ring of the bell on the day assigns it a market valuation of $2.57B. That closing price of EWTX’s stock is at a discount of -40.66% from its 52-week high price of $38.12 and is indicating a premium of 45.02% from its 52-week low price of $14.90.
For Edgewise Therapeutics Inc (EWTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.25. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Edgewise Therapeutics Inc (NASDAQ:EWTX) trade information
Upright in the green during last session for gaining 1.61%, in the last five days EWTX remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $27.10 price level, adding 7.0% to its value on the day. Edgewise Therapeutics Inc’s shares saw a change of 1.50% in year-to-date performance and have moved 4.84% in past 5-day. Edgewise Therapeutics Inc (NASDAQ:EWTX) showed a performance of -1.06% in past 30-days.
Wall Street analysts have assigned a consensus price target of 46 to the stock, which implies a rise of 41.09% to its current value. Analysts have been projecting 42 as a low price target for the stock while placing it at a high target of 51. It follows that stock’s current price would drop -54.98% in reaching the projected high whereas dropping to the targeted low would mean a loss of -54.98% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -68.02% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 5.75% while estimates for its earnings growth in next 5 years are of -12.14%.
Edgewise Therapeutics Inc (NASDAQ:EWTX)’s Major holders
ORBIMED ADVISORS LLC is the top institutional holder at EWTX for having 15.02 million shares of worth $270.54 million. And as of 2024-06-30, it was holding 16.0634 of the company’s outstanding shares.
The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 8.91 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.5269 of outstanding shares, having a total worth of $160.45 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 2.54 shares of worth $68.81 million or 2.68% of the total outstanding shares. The later fund manager was in possession of 2.06 shares on Nov 30, 2024 , making its stake of worth around $55.77 million in the company or a holder of 2.17% of company’s stock.
